𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Ursodeoxycholic acid for primary biliary cirrhosis: final results of a 12-year, prospective, randomized, controlled trial

✍ Scribed by George V Papatheodoridis; Emilia S Hadziyannis; Melanie Deutsch; Stephanos J Hadziyannis

Book ID
119392548
Publisher
Nature Publishing Group
Year
2002
Tongue
English
Weight
92 KB
Volume
97
Category
Article
ISSN
0002-9270

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A randomized, double-blind, placebo-cont
A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
✍ Burton Combes; Robert L. Carithers Jr.; Willis C. Maddrey; Danyu Lin; Dr Mary F. πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 792 KB

One hundred fifty-one patients with primary biliary cirrhosis (PBC) grouped into four strata based on entry serum bilirubin (<2 mg/dL vs. 2 mg/dL or greater) and liver histology (stages I, 1 1 vs. stages 111, IV-Ludwig criteria) were randomized within each stratum to ursodiol or placebo given in a s

The canadian multicenter double-blind ra
The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosis
✍ E. Jenny Heathcote; Karen Cauch-Dudek; Valery Walker; Robert J. Bailey; Laurence πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 969 KB

Ursodeoxycholic acid, a dihydroxyl bile acid normally present in human beings in minimal amounts, becomes incorporated into the bile salt pool when taken orally. In cholestasis, bile acids are retained in the liver and are hepatotoxic. Ursodeoxycholic acid is the least-known hepatotoxic bile acid, h